|
Age, y, (IQR)
|
58 (51 ~ 67)
|
64 (57 ~ 71)
|
0.005*
|
|
Gender, male, N (%)
|
70 (69.3)
|
26 (63.4)
|
0.497
|
|
Smoke, N (%)
|
53 (52.5)
|
21 (51.2)
|
0.892
|
|
Drink, N (%)
|
44 (43.6)
|
14 (34.1)
|
0.302
|
|
Hypertension, N (%)
|
50 (49.5)
|
21 (51.2)
|
0.853
|
|
Diabetes mellitus, N (%)
|
18 (17.8)
|
9 (22)
|
0.570
|
|
Previous stroke, N (%)
|
16 (15.8)
|
13 (31.7)
|
0.037*
|
|
Preexisting coronary heart disease, N (%)
|
9 (8.9)
|
10 (24.4)
|
0.018*
|
|
KAF
|
8 (7.9)
|
13 (31.7)
|
0.001*
|
|
Treatment, N (%)
|
|
Conservative (reference)
|
79 (78.2)
|
34 (82.9)
| |
|
Intravenous thrombolysis
|
16 (15.8)
|
4 (9.8)
|
0.362
|
|
Endovascular intervention
|
6 (5.9)
|
3 (7.3)
|
0.839
|
|
NIHSS (IQR)
|
18 (15 ~ 20)
|
21 (20 ~ 22)
|
< 0.001*
|
|
MLS, mm (IQR)
|
1.9 (3.6 ~ 5.1)
|
5.6 (4.9 ~ 8.1)
|
< 0.001*
|
|
Baseline temperature, °C (IQR)
|
36.5 (36.4 ~ 36.8)
|
36.5 (36.5 ~ 37.1)
|
0.170
|
|
ACA territory involvement, N (%)
|
9 (8.9)
|
18 (43.9)
|
< 0.001*
|
|
PCA territory involvement, N (%)
|
27 (26.7)
|
24 (58.5)
|
< 0.001*
|
|
Basal ganglia involvement, N (%)
|
60 (59.4)
|
37 (90.2)
|
0.001*
|
|
Cerebral hemisphere, right, N (%)
|
56 (55.4)
|
15 (36.6)
|
0.044*
|
|
Systolic pressure, mmHg, (IQR)
|
145 (127 ~ 166)
|
141 (120 ~ 159)
|
0.168
|
|
Diastolic pressure, mmHg, (IQR)
|
83 (73 ~ 95)
|
80 (74 ~ 92)
|
0.871
|
|
FBG, mmol/L, (IQR)
|
5.9 (5.4 ~ 6.8)
|
7.1 (5.8 ~ 9.2)
|
0.002*
|
|
HbA1c, %, (IQR)
|
5.6 (5.3 ~ 6.1)
|
5.7 (5.3 ~ 6.1)
|
0.378
|
